Induction of Apoptosis by Miltefosine in Iranian Strain of Leishmania infantum Promastigotes

被引:0
作者
Khademvatan, S. [1 ]
Gharavi, M. J. [1 ]
Akhlaghi, L. [1 ]
Samadikuchaksaraei, A. [2 ]
Oormazdi, H. [1 ]
Mousavizadeh, K. [3 ]
Hadighi, R. [1 ]
Saki, J. [1 ]
机构
[1] Iran Univ Med Sci, Sch Med, Dept Med Parasitol & Mycol, Tehran, Iran
[2] Iran Univ Med Sci, Dept Biotechnol, Cellular & Mol Res Ctr, Tehran, Iran
[3] Iran Univ Med Sci, Dept Basic Sci, Tehran, Iran
关键词
Leishmania infantum; Miltefosine; IC50; Apoptosis; Iran; VISCERAL LEISHMANIASIS; DONOVANI PROMASTIGOTES; ORAL MILTEFOSINE; CELL-DEATH; TRIAL; ACTIVATION;
D O I
暂无
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Background: Miltefosine is a new drug of choice for the treatment of visceral leishmaniasis. Numerous experimental studies have shown miltefosine is effective on Leishmania donovani, however, effectiveness of miltefosine in treatment of L. infantum is not fully understood. The aims of the present study were to evaluate cytotoxic effects of miltefosine on Iranian strain of L. infantum, and to determine its 50% inhibitory concentration (IC50) as well as lethal dose. Methods: Anti-L. infantum activity of miltefosine was studied by treatment of cultured promastigotes with various concentration of miltefosine. MTT assay was used to determine L. infantum viability and the results were expressed as IC50. Annexin-V FLUOS staining was performed to study apoptotic properties of this drug by using FACS flow cytometry. Results: Miltefosine led to dose-dependent death of L. infantum with features compatible with apoptosis including cell shrinkage, DNA laddering, and externalization of phosphatidylserine with preservation of integrity of plasma membrane. The 100% effect was achieved at 22 mu M and IC50 after 48 hours of incubation was 7 mu M. Conclusion: Miltefosine exerts cytotoxic effect on Iranian strain of L. infantum via an apoptosis-related mechanism.
引用
收藏
页码:23 / 31
页数:9
相关论文
共 26 条
[21]   Trial of oral miltefosine for visceral leishmaniasis [J].
Sundar, S ;
Rosenkaimer, F ;
Makharia, MK ;
Goyal, AK ;
Mandal, AK ;
Voss, A ;
Hilgard, P ;
Murray, HW .
LANCET, 1998, 352 (9143) :1821-1823
[22]   Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer [J].
Terwogt, JMM ;
Mandjes, IAM ;
Sindermann, H ;
Beijnen, JH ;
Huinink, WWTB .
BRITISH JOURNAL OF CANCER, 1999, 79 (7-8) :1158-1161
[23]   Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction [J].
Verma, Navin K. ;
Singh, Gaganineet ;
Dey, Chinmoy S. .
EXPERIMENTAL PARASITOLOGY, 2007, 116 (01) :1-13
[24]   Possible mechanism of miltefosine-mediated death of Leishmania donovani [J].
Verma, NK ;
Dey, CS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) :3010-3015
[25]   Apoptotic mimicry:: an altruistic behavior in host/Leishmania interplay [J].
Wanderley, JLM ;
Benjamin, A ;
Real, F ;
Bonomo, A ;
Moreira, MEC ;
Barcinski, MA .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2005, 38 (06) :807-812
[26]   Successful treatment of a married couple for American leishmaniasis with miltefosine [J].
Woehrl, S. ;
Schnedl, J. ;
Auer, H. ;
Walochnik, J. ;
Stingl, G. ;
Geusau, A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (02) :258-259